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In pharmaceutical research and drug development,
machine learning methods play an important role in vir-
tual screening and ADME/Tox prediction. For the applica-
tion of such methods, a formal measure of similarity
between molecules is essential. Such a measure, in turn,
depends on the underlying molecular representation.
Input samples have traditionally been modeled as vectors.
Consequently, molecules are represented to machine
learning algorithms in a vectorized form using molecular
descriptors. While this approach is straightforward, it has
its shortcomings. Amongst others, the interpretation of
the learned model can be difficult, e.g. when using finger-
prints or hashing.
Structured representations of the input constitute an alter-
native to vector based representations, a trend in machine
learning over the last years. For molecules, there is a rich
choice of such representations. Popular examples include
the molecular graph, molecular shape and the electro-
static field.
We have developed a molecular similarity measure
defined directly on the (annotated) molecular graph, a
long-standing established topological model for mole-
cules. It is based on the concepts of optimal atom assign-
ments and iterative graph similarity. In the latter, two
atoms are considered similar if their neighbors are similar.
This recursive definition leads to a non-linear system of
equations. We show how to iteratively solve these equa-
tions and give bounds on the computational complexity
of the procedure. Advantages of our similarity measure
include interpretability (atoms of two molecules are
assigned to each other, each pair with a score expressing
local similarity; this can be visualized to show similar
regions of two molecules and the degree of their similar-
ity) and the possibility to introduce knowledge about the
target where available. We retrospectively tested our simi-
larity measure using support vector machines for virtual
screening on several pharmaceutical and toxicological
datasets, with encouraging results. Prospective studies are
under way.
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